20n Bio
PrivateLast Round
Seed
May 20, 2026
Total Funding Raised
$10.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
20n Bio operates in Healthcare & Life Sciences and is based in Malvern, Pennsylvania. Its latest recorded funding round was a Seed round in May 2026.
20n Bio is a biotechnology company that utilizes an AI-powered high-throughput screening platform to discover and develop novel cyclic peptide therapeutics for oncology and other genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
20n Bio Comparables
Compare 20n Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Menten AI | 83% | |
| Dayra Therapeutics | 82% | |
| AbbVie | 82% |
For institutional investors. Book with your work email.
20n Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 20, 2026 | ||||
| Seed | Dec 17, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
20n Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lanchi Ventures | Seed |
| Lanchi Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 414% MoM, from 805 to 4.1K.
- Dec 17, 2021
$3.3M round led by Lanchi Ventures
For institutional investors. Book with your work email.
20n Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 20n Bio's valuation, stock price, and market status.
Is 20n Bio a public or private company?
20n Bio is a private company.
What is the current stock price of 20n Bio?
20n Bio is a private company, so its shares have no public market price. Caplight tracks 20n Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 20n Bio worth (valuation)?
Valuation information for 20n Bio is not publicly available.
Can I buy 20n Bio stock?
20n Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 20n Bio's last funding round?
20n Bio's most recent funding round was Seed on May 20, 2026.
Who are the main investors in 20n Bio?
Key investors in 20n Bio include Lanchi Ventures, Lanchi Ventures.
Will 20n Bio IPO soon?
No public IPO plans have been announced for 20n Bio.
How can I track 20n Bio secondary market activity?
Caplight tracks bids, offers, and trades in 20n Bio's shares on secondary markets.